79 results on '"WIKSTROM, H"'
Search Results
2. Symptoms of severe serotonin syndrome – A pooled case analysis
3. Chapter 5 Advances in Central Serotonergics
4. Bivalirudin versus Heparin Monotherapy in Myocardial Infarction
5. Comparison between electrochemistry/mass spectrometry and cytochrome P450 catalyzed oxidation reactions
6. Additions and Corrections A new type of prodrug of catecholamines: An opportunity to improve the treatment of Parkinson's disease (vol 45, pg 2349, 2002)
7. Electrochemically assisted Fenton reaction: reaction of hydroxyl radicals with xenobiotics followed by on-line analysis with high-performance liquid chromatography/tandem mass spectrometry
8. Evoked magnetic fields from primary and secondary somatosensory cortices: A reliable tool for assessment of cortical processing in the neonatal period
9. New selective and potent 5-HT 1B/1D antagonists: Chemistry and pharmacological evaluation of N-piperazinylphenyl biphenylcarboxamides and biphenylsulfonamides
10. Temperature effects on the chromatographic behaviour of racemic 2-aminotetralins on a Whelk-O 1 stationary phase in super- and subcritical fluid chromatography
11. Somatosensory evoked magnetic fields from the primary and secondary somatosensory cortices in healthy newborns
12. Atypical antipsychotic-like effects of the dopamine D-3 receptor agonist, (+)-PD 128,907
13. [carbonyl-C-11]desmethyl-WAY-100635 (DWAY) is a potent and selective radioligand for central 5-HT1A receptors in vitro and in vivo
14. GRID/GOLPE 3D-QSAR Study on a Set of Benzamides and Naphtamides, with Affinity for the Dopamine D3 Receptor Subtype
15. Characterization of the radioactive metabolites of the 5-HT1A receptor radioligand, [O-methyl-C-11]WAY-100635, in monkey and human plasma by HPLC: Comparison of the behaviour of an identified radioactive metabolite with parent radioligand in monkey using PET
16. Impact of substituents on the enantioseparation of racemic 2-amidotetralins on polysaccharide stationary phases .1. Chiralcel OD
17. Neurochemical and functional characterization of the preferentially selective dopamine D3 agonist PD 128907
18. STRUCTURE-ACTIVITY-RELATIONSHIPS IN THE 8-AMINO-6,7,8,9-TETRAHYDRO-3H-BENZ[E]INDOLE RING-SYSTEM .1. EFFECTS OF SUBSTITUENTS IN THE AROMATIC SYSTEM ON SEROTONIN AND DOPAMINE-RECEPTOR SUBTYPES
19. SYNTHESIS AND EVALUATION OF PHARMACOLOGICAL AND PHARMACOKINETIC PROPERTIES OF MONOPROPYL ANALOGS OF 5-[[(TRIFLUOROMETHYL)SULFONYL]OXY]-2-AMINOTETRALIN, 7-[[(TRIFLUOROMETHYL)SULFONYL]OXY]-2-AMINOTETRALIN, AND 8-[[(TRIFLUOROMETHYL)SULFONYL]OXY]-2-AMINOTETRALIN - CENTRAL DOPAMINE AND SEROTONIN RECEPTOR ACTIVITY
20. 6,7,8,9-TETRAHYDRO-N,N-DI-N-PROPYL-3H-BENZINDOL-8-AMINES - DERIVATIVES AS POTENT AND ORALLY-ACTIVE SEROTONIN 5-HT1A RECEPTOR AGONISTS
21. SUBSTITUTED (S)-PHENYLPIPERIDINES AND RIGID CONGENERS AS PREFERENTIAL DOPAMINE AUTORECEPTOR ANTAGONISTS - SYNTHESIS AND STRUCTURE-ACTIVITY-RELATIONSHIPS
22. ORALLY-ACTIVE CENTRAL DOPAMINE AND SEROTONIN RECEPTOR LIGANDS - 5-[[(TRIFLUOROMETHYL)SULFONYL]OXY]-2-(DI-N-PROPYLAMINO)TETRALINS, 6-[[(TRIFLUOROMETHYL)SULFONYL]OXY]-2-(DI-N-PROPYLAMINO)TETRALINS, 7-[[(TRIFLUOROMETHYL)SULFONYL]OXY]-2-(DI-N-PROPYLAMINO)TETRALINS, AND 8-[[(TRIFLUOROMETHYL)SULFONYL]OXY]-2-(DI-N-PROPYLAMINO)TETRALINS AND THE FORMATION OF ACTIVE METABOLITES IN-VIVO
23. 5, 6, 7 AND 8-AMINO-2-(N,N-DI-N-PROPYLAMINO)-1,2,3,4-TETRAHYDRONAPHTHALENES - CENTRALLY ACTING DA AND 5-HT(1A) AGONISTS
24. ROLE OF DOPAMINE IN DRUG-DEPENDENCE AND WITHDRAWAL
25. Novel 5-HT<INF>7</INF> Receptor Inverse Agonists. Synthesis and Molecular Modeling of Arylpiperazine- and 1,2,3,4-Tetrahydroisoquinoline-Based Arylsulfonamides
26. Characterization of the 5-HT<INF>7</INF> Receptor. Determination of the Pharmacophore for 5-HT<INF>7</INF> Receptor Agonism and CoMFA-Based Modeling of the Agonist Binding Site
27. Orally Active Oxime Derivatives of the Dopaminergic Prodrug 6-(N,N-Di-n-propylamino)-3,4,5,6,7,8-hexahydro-2H-naphthalen-1-one. Synthesis and Pharmacological Activity
28. Orally Active Analogues of the Dopaminergic Prodrug 6-(N,N-Di-n-propylamino)-3,4,5,6,7,8-hexahydro-2H-naphthalen-1-one: Synthesis and Pharmacological Activity
29. Further Characterization of Structural Requirements for Ligands at the Dopamine D<INF>2</INF> and D<INF>3</INF> Receptor: Exploring the Thiophene Moiety
30. Synthesis and Pharmacological Testing of 1,2,3,4,10,14b-Hexahydro-6-methoxy-2-methyldibenzo[c,f]pyrazino[1,2-a]azepin and Its Enantiomers in Comparison with the Two Antidepressants Mianserin and Mirtazapine
31. Development and validation of a capillary electrophoresis method for ximelagatran assay and related substance determination in drug substance and tablets
32. Electrooxidation Potential as a Tool in the Early Screening for New Safer Clozapine-like Analogues
33. Ion-pair formation of hydroquinine by chromatography
34. New halogenated [11C]WAY analogues, [11C]6FPWAY and [11C]6BPWAY-Radiosynthesis and assessment as radioligands for the study of brain 5-HT1A receptors in living monkey
35. Short and efficient syntheses of analogues of way-100635: new and potent 5-HT1A receptor antagonists
36. Antipsychotic drugs classified by their effects on the release of dopamine and noradrenaline in the prefrontal cortex and striatum
37. Is the beneficial antidepressant effect of coadministration of pindolol really due to somatodendritic autoreceptor antagonism?
38. Thiazoloindans and Thiazolobenzopyrans: A Novel Class of Orally Active Central Dopamine (Partial) Agonists
39. Synthesis and Pharmacological Evaluation of Thiopyran Analogues of the Dopamine D<INF>3</INF> Receptor-Selective Agonist (4aR,10bR)-(+)-trans-3,4,4a,10b- Tetrahydro-4-n-propyl-2H,5H-[1]benzopyrano[4,3-b]-1,4-oxazin-9-ol (PD 128907)
40. Synthesis and in Vitro and in Vivo Functional Studies of Ortho-Substituted Phenylpiperazine and N-Substituted 4-N-(o-Methoxyphenyl)aminopiperidine Analogues of WAY100635
41. New Selective and Potent 5-HT<INF>1B/1D</INF> Antagonists: Chemistry and Pharmacological Evaluation of N-Piperazinylphenyl Biphenylcarboxamides and Biphenylsulfonamides
42. Radioligands for the study of brain 5-HT1A receptors in vivo-development of some new analogues of way
43. Desensitisation of 5-HT autoreceptors upon pharmacokinetically monitored chronic treatment with citalopram
44. Augmentation with a 5-HT1A, but not a 5-HT1B receptor antagonist critically depends on the dose of citalopram
45. Dynamics of mu-rhythm suppression caused by median nerve stimulation: a magnetoencephalographic study in human subjects
46. Thiophene analogs of naphthoxazines and 2-aminotetralins: bioisosteres with improved relative oral bioavailability, as compared to 5-OH-DPAT
47. Somatosensory evoked magnetic fields: relation to pre-stimulus mu rhythm
48. Enantioselective reversed-phase and non-aqueous capillary electrochromatography using a teicoplanin chiral stationary phase
49. Immobilisation and evaluation of a vancomycin chiral stationary phase for capillary electrochromatography
50. Somatosensory evoked magnetic fields from the primary somatosensory cortex (SI) in acute stroke
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.